Knoll Capital Management LLC 13D/13G Filings for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Knoll Capital Management LLC 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-01-16
10:45 am
Purchase
2023-12-2613GCORBUS PHARMACEUTICALS HOLDING
CRBP
Knoll Capital Management LLC3,881,879
9.967%
3,799,070increase
(+4587.75%)
Filing